Last quarter (Q3 2024), Turnstone Biologics Corp.'s total revenue was $135.00K, an increase of Infinity% from previous quarter. In Q3, Turnstone Biologics Corp.'s net income was $-17.03M. See Turnstone Biologics Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23
Total Revenue
$ 19.31M
Cost of Revenue
-
Gross Profit
$ 19.31M
Operating Expense
$ 78.34M
Operating Income
$ -59.03M
Net Non Operating Interest Income Expense
-
Other Income Expense
$ -3.55M
Pretax Income
$ -55.49M
Tax Provision
$ -286.00K
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
$ -55.24M
Basic EPS
$ -4.78
Diluted EPS
$ -4.78
Basic Average Shares
$ 11.56M
Diluted Average Shares
$ 11.56M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
$ 78.34M
Net Income From Continuing And Discontinued Operation
$ -55.20M
Normalized Income
$ -53.87M
Interest Expense
-
EBIT
$ -55.49M
EBITDA
$ -52.69M
Currency in USD
Turnstone Biologics Corp. Earnings and Revenue History